Associated Papers
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma.
Chen Z et al.
Leukemia, 2024
No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma.
Ong SY et al.
Haematologica, 2021
Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.
Montes-Mojarro IA et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2020
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma.
Li Z et al.
Nature Communications, 2019
Molecular pathogenic pathways in extranodal NK/T cell lymphoma.
de Mel S et al.
Journal of Hematology & Oncology, 2019
Whole exome sequencing identified a novel truncation mutation in the NHS gene associated with Nance-Horan syndrome.
Ling C et al.
Bmc Medical Genetics, 2019
30642278 (PubMed )
Supplement: 12881_2018_725_MOESM2_ESM.xlsx › Sheet1
Advances in multiple omics of natural-killer/T cell lymphoma.
Xiong J et al.
Journal of Hematology & Oncology, 2018
An Essential Role for ECSIT in Mitochondrial Complex I Assembly and Mitophagy in Macrophages.
Carneiro FRG et al.
Cell Reports, 2018
Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma.
Wen H et al.
Nature Medicine, 2018
Select a paper to view details